Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β-catenin signaling pathway

被引:22
|
作者
Liu, Xia [1 ]
Peng, Jiamin [2 ]
Zhou, Yayun [2 ]
Xie, Bei [2 ]
Wang, Jianchao [3 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 2, Cent Lab, 318 C haowang Rd, Hangzhou 310005, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Clin Med Coll 2, Hangzhou 310005, Zhejiang, Peoples R China
[3] Zhejiang Tongde Hosp Zhejiang Prov, Dept Clin Lab, 234 Gucui Rd, Hangzhou 310012, Zhejiang, Peoples R China
关键词
multiple myeloma; ribonucleotide reductase M2; DNA damage; apoptosis; Wnt/beta-catenin signaling; RIBONUCLEOTIDE REDUCTASE M2; THERAPEUTIC TARGET; RNA INTERFERENCE; CANCER; SUBUNIT; EXPRESSION; CELLS; SUPPRESSION; APOPTOSIS; PROMOTES;
D O I
10.3892/mmr.2019.10465
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribonucleotide reductase M2 (RRM2) is one of the two subunits that comprise ribonucleotide reductase (RR), the enzyme that catalyzes the conversion of ribonucleotide 5'-diphosphates into 2'-deoxyribonucleotides, which are required for DNA synthesis. RRM2 is a stress response factor important for the development of several tumors. However, its role in multiple myeloma (MM) remains to be fully elucidated. The present study aimed to investigate the role of RRM2 in MM. The expression of RRM2 in patients with MM was analyzed using the Oncomine database. The results demonstrated that RRM2 expression was higher in MM compared with healthy subjects. Reverse transcription-quantitative polymerase chain reaction and western blot results revealed that RRM2 expression was decreased following transfection with a small interfering RNA targeting RRM2 into NCI-H929 cells. RR activity and Cell Counting Kit-8 assays demonstrated that RRM2 silencing reduced RR activity and inhibited cell proliferation. Annexin V-propidium iodide staining indicated that the percentage of apoptotic NCI-H929 cells was increased following RRM2 silencing compared with that in the control group. Increased phosphorylation of H2AX indicated that RRM2 silencing may activate the DNA-damage response pathway in NCI-H929 cells. Western blot analysis revealed that protein levels of the apoptosis-associated factor Bcl-2 were reduced, whereas Bax, cleaved caspase-3 and cleaved poly(ADP-ribose) polymerase 1 were upregulated following RRM2 silencing compared with the control group. In addition, the results demonstrated that RRM2 silencing may inhibit target gene expression in the Wnt/beta-catenin signaling pathway by increasing the phosphorylation of glucose synthase kinase 3 beta. These findings indicated that RRM2 may be involved in the proliferation and apoptosis of MM cells via the Wnt/beta-catenin signaling pathway, suggesting that RRM2 may represent a novel therapeutic target for MM.
引用
收藏
页码:2159 / 2166
页数:8
相关论文
共 50 条
  • [11] Targeting the Wnt/ββ-catenin signaling pathway in human cancers
    Yao, Hisayuki
    Ashihara, Eishi
    Maekawa, Taira
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (07) : 873 - 887
  • [12] Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer
    Patergnani, Simone
    Buchsbaum, Donald J.
    Piazza, Gary A.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [13] Natural Products Targeting Wnt/β-catenin Signaling Pathway
    Kim, Donghwa
    Lee, Sang Kook
    NATURAL PRODUCT SCIENCES, 2020, 26 (02): : 109 - 117
  • [14] Silencing Celsr2 inhibits the proliferation and migration of Schwann cells through suppressing the Wnt/β-catenin signaling pathway
    Zhou, Xiang
    Zhan, Zhaoying
    Tang, Chaogang
    Li, Jiachun
    Zheng, Xiaoju
    Zhu, Shuang
    Qi, Jian
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (04) : 623 - 630
  • [15] Influencing the Wnt Signaling Pathway in Multiple Myeloma
    Kim, Young
    Reifenberger, Guido
    Lu, Desheng
    Endo, Tomoyuki
    Carson, Dennis A.
    Gast, Sanna-Marie
    Meschenmoser, Karoline
    Nowak, Michael
    Schmidt-Wolf, Ingo G. H.
    ANTICANCER RESEARCH, 2011, 31 (02) : 725 - 730
  • [16] Wnt/β-catenin deficiency inhibits multiple myeloma cell growth via AMPK/mTOR signaling
    Su, Nan
    Wang, Pingping
    Liang, Ying
    Li, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 5657 - 5665
  • [17] Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/β-catenin signaling pathway and the epithelial-mesenchymal transition process
    He, Hongchao
    Dai, Jun
    Yang, Xiaoqun
    Wang, Xiaojing
    Sun, Fukang
    Zhu, Yu
    BIOLOGICAL CHEMISTRY, 2018, 399 (06) : 593 - 602
  • [18] AV-65, a Novel Inhibitor of the Wnt/β-Catenin Signaling Pathway, Inhibits the Proliferation of Myeloma Cells
    Yao, Hisayuki
    Ashihara, Eishi
    Nagao, Rina
    Kimura, Shinya
    Hirai, Hideyo
    Strovel, Jeffrey W.
    Padia, Janak
    Cholody, Wieslaw M.
    Maekawa, Taira
    BLOOD, 2009, 114 (22) : 1119 - 1119
  • [19] Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
    Hui Cheng
    Qinfang Li
    BMC Gastroenterology, 23
  • [20] Sevoflurane inhibits cholangiocarcinoma via Wnt/β- catenin signaling pathway
    Cheng, Hui
    Li, Qinfang
    BMC GASTROENTEROLOGY, 2023, 23 (01)